ABBS publishes papers based on original research that are judged, after editorial review, to make a novel and important contribution to the understanding of any area of biochemistry, biophysics or molecular biology. Manuscripts may be submitted for consideration as Regular Papers or Accelerated Publications. ABBS also publishes Reviews, all of which are by invitation only. Authors are urged to keep the length of Regular Papers to six printed pages or less. Accelerated Publications are intended to present new information of exceptional novelty, importance and interest to the broad readership of ABBS. Accelerated Publications must be four printed pages or less, including all figures, references and tables. They are not intended simply to be short versions of Regular Papers.

For detailed submission instructions see http://www.abbs.info/instrauthor.htm

It is the responsibility of the Editor-in-Chief, the Associate Editors, and the Editorial Board to determine the suitability of a manuscript for publication. After receipt of a manuscript by the Editor, it is sent to an Associate Editor who usually assigns it to a member of the Editorial Board. The Board member then makes a recommendation for acceptance, revision, or declination based on the scientific merit and technical quality of the studies reported. Reviewers may be consulted when additional expertise is required.

All Board members and reviewers who review a manuscript remain unknown to the authors. Every manuscript is treated by the editors and reviewers as privileged information, and they are instructed to exclude themselves from review of any manuscript that might involve a conflict of interest or the appearance thereof.

The primary criteria for judging the acceptability of a manuscript are its novelty and scientific importance. Manuscripts judged lacking in these respects will be declined, even if the experimental work appears technically sound. This policy permits declination of a manuscript solely on the Editorial Board' s judgment that the studies reported are not sufficiently novel or important to merit publication in ABBS.

As a condition of publication, all authors must transfer copyright to Insitute of Biochemistry and Cell Biology. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the submission and that the final version of the manuscript has been seen and approved by all authors.

Authors of papers published in ABBS are obligated to honor any reasonable request by qualified investigators for unique propagative materials, such as cell lines, hybridomas, DNA clones, and organisms that are described in the paper. The primary data obtained from genome- or proteome- scale analyses must be submitted for review in electronic form and, if the manuscript is accepted, must be published as Supplemental Information in ABBS On-line. If computer software programs are developed and used in submitted manuscripts, the programs must be made available to the reviewer upon request. The source code or the program must be made available, either commercially or in downloadable form from the authors, if the manuscript is accepted for publication. The Editors may deny further publication rights in ABBS to authors unwilling to abide by these principles.